Choice ClinOps: Cancer and Rare Disease Clinical Trials Operations Partner

Fractional Global Clinical Operations Leadership, Governance, and Execution

Embedded executive ClinOps leadership, governance, and execution for global oncology, rare disease, and gene therapy sponsors

Book a Diagnostic

View Services

Executive Global Clinical Operations

fractional, Embedded clinical trial operations LEADERSHIP

CRO, Vendor, And Site Governance and Oversight

fractional, Embedded clinical trial operations LEADERSHIP

Global Study Rescue ACCELERATOR

fractional, Embedded clinical trial operations LEADERSHIP

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

merger and acquisition (M&A) CLINICAL TRIAL OPERATIONS Harmonization

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

merger and acquisition (M&A) CLINICAL TRIAL OPERATIONS Harmonization

site network readiness and optimization

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

merger and acquisition (M&A) CLINICAL TRIAL OPERATIONS Harmonization

Not a CRO. Not staffing. Not generic consulting.

Fractional and Embedded Executive-Grade Leadership

Choice ClinOps is the sponsor-side clinical operations command center for small and midsize companies running global high-risk, high-value oncology, rare disease, and gene therapy programs.

We step in when internal bandwidth is stretched or the expertise is missing, visibility is slipping, vendors are drifting, sites are underperforming, or a major transition (e.g. merger, acquisition, CRO change) threatens continuity.

The result is stronger control, faster execution, better stakeholder alignment, and lower operational risk without the fixed overhead of a full-time executive hire.

Avoiding Costly Clinical Trial Delays

You do not have a staffing problem. You have an execution-control problem.

When clinical operations does not have enough sponsor-side governance or specific expertise, clinical trial value - and study funds - can erode quickly.

Internal teams are carrying too much complexity without enough senior operating capacity.
CROs and vendors are active, but sponsor visibility, governance, and accountability are too thin.
M&A, portfolio growth, and trial expansion create fragmentation across teams, systems, timelines, and decision rights.
Site startup, enrollment, communication, and execution consistency are not where they need to be.

In oncology, rare disease, and gene therapy, execution drift is not administrative. It is enterprise risk.

Where Choice ClinOps Creates Value

Strategic global Clinical Operations Leadership

Merger and Acquisition (M&A) Clinical Operations Continuity

Strategic global Clinical Operations Leadership

Fractional executive clinical operations leadership integrated into your team at the level and amount your portfolio requires to strengthen global clinical trial operations governance, execution, oversight, continuity, and sponsor control - across North America, LATAM, EMEA, and APAC.

Study Rescue Accelerator

Merger and Acquisition (M&A) Clinical Operations Continuity

Strategic global Clinical Operations Leadership

Restore governance, alignment, and execution in delayed or drifting studies.

Merger and Acquisition (M&A) Clinical Operations Continuity

Protect global clinical operations continuity, governance, and ROI across acquired assets, teams, vendors, and workflows.

Global CRO, Vendor, and site Governance

Merger and Acquisition (M&A) Clinical Operations Continuity

Strengthen governance, accountability, communication, execution, oversight, and performance across external partners - throughout North America, LATAM, EMEA, and APAC.

Silos eliminated.
Clarity gained.
Objectives achieved.
Surprise change orders eliminated.

Learn More

Site Readiness and Optimization

Global CRO, Vendor, and site Governance

Site Readiness and Optimization

Accelerate site readiness, strengthen site oversight, communication, engagement, and execution consistency.

Start with an Executive Diagnostic

When the science is valuable, execution cannot be left to chance.

A fast, focused assessment for sponsors that need clarity before delay, drift, or fragmentation become more expensive.

Identify governance gaps, operational and execution risk, clarify priorities, and define the highest-impact next steps.

Study Rescue Risk Diagnostic
M&A Clinical Operations Continuity Assessment
CRO and Vendor Governance Health Check
Site Network Performance Audit

Each diagnostic is designed to identify the highest-priority operational risks, define near-term action paths, and give leadership a sharper decision framework.

Fractional Global Clinical Operations Leadership, Governance, and Execution

Executive Global Clinical Operations

fractional, Embedded clinical trial operations LEADERSHIP

fractional, Embedded clinical trial operations LEADERSHIP

fractional, Embedded clinical trial operations LEADERSHIP

CRO, Vendor, And Site Governance and Oversight

fractional, Embedded clinical trial operations LEADERSHIP

fractional, Embedded clinical trial operations LEADERSHIP

Global Study Rescue ACCELERATOR

fractional, Embedded clinical trial operations LEADERSHIP

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

merger and acquisition (M&A) CLINICAL TRIAL OPERATIONS Harmonization

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

merger and acquisition (M&A) CLINICAL TRIAL OPERATIONS Harmonization

site network readiness and optimization

21+ years of clinical trial operations execution across North America, LATAM, EMEA, and APAC

merger and acquisition (M&A) CLINICAL TRIAL OPERATIONS Harmonization

Partner for study rescue, M&A harmonization, and CRO, vendor, and site governance globally.

Not a CRO. Not staffing. Not generic consulting.

Fractional and Embedded Executive-Grade Leadership

Avoiding Costly Clinical Trial Delays

You do not have a staffing problem. You have an execution-control problem.

Where Choice ClinOps Creates Value

Strategic global Clinical Operations Leadership

Merger and Acquisition (M&A) Clinical Operations Continuity

Strategic global Clinical Operations Leadership

Study Rescue Accelerator

Merger and Acquisition (M&A) Clinical Operations Continuity

Strategic global Clinical Operations Leadership

Merger and Acquisition (M&A) Clinical Operations Continuity

Merger and Acquisition (M&A) Clinical Operations Continuity

Merger and Acquisition (M&A) Clinical Operations Continuity

Global CRO, Vendor, and site Governance

Global CRO, Vendor, and site Governance

Merger and Acquisition (M&A) Clinical Operations Continuity

Site Readiness and Optimization

Global CRO, Vendor, and site Governance

Site Readiness and Optimization

21+ Years

30+ Countries

50+ Clinical Trials

$137M+ Managed

Six-Figure Cost Avoidance

Choice ClinOps Founder

Led by Leila Cupersmith

Start with an Executive Diagnostic

When the science is valuable, execution cannot be left to chance.

Valuable science needs disciplined execution.

Subscribe to weekly Choice ClinOps real-time blog posts

Oncology Participant Retention Playbook

Weekly Executive ClinOps Insights

Global oncology, rare diseases, & gene therapy trials

Let's Connect

Contact Choice ClinOps

Fractional, embedded executive ClinOps leadership

Contact Us

This website uses cookies.